Skip to main content

Rhesus-Negative Mother

  • Chapter
  • First Online:
Labour Room Emergencies
  • 1006 Accesses

Abstract

Hemolytic disease of the newborn (HDN) secondary to rhesus alloimmunization was once a major contributor to perinatal morbidity and mortality. However, with the advent of anti-D immunoprophylaxis, the disease prevalence and the associated morbidity and mortality are markedly reduced with approximately 1–6 cases occurring every 1000 live births [1]. However, the disease is still a major problem in developing countries, including India with an estimated 56,700 cases of Rh-HDN occurring annually [2].

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 139.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD 179.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Moise KJ. Management of rhesus alloimmunization in pregnancy. Obstet Gynecol. 2002;100:600–11.

    PubMed  Google Scholar 

  2. Mathai SS, Venkatnarayan K. Jaundice in the newborn. In: Gupta P, Menon PSN, Ramji S, Lodha R, editors. PG textbook of pediatrics. 1st ed. New Delhi: Jaypee Brothers Medical Publishers(P) Ltd; 2015. p. 435–45.

    Google Scholar 

  3. American College of Obstetricians and Gynecologists. Management of alloimmunization during pregnancy. In: ACOG practice bulletin no. 75. Washington, DC: American College of Obstetricians and Gynecologists; 2006.

    Google Scholar 

  4. Recommendations for the use of anti-D immunoglobulin. Prescribers J. 1991;1:137–45.

    Google Scholar 

  5. Bowman JM, Pollock JM, Penston LE. Fetomaternal transplacental hemorrhage during pregnancy and after delivery. Vox Sang. 1986;51:117–21.

    Article  CAS  Google Scholar 

  6. Royal College of Obstetricians and Gynaecologists (RCOG). The management of women with red cell antibodies during pregnancy. Green-top Guidelines no. 65 May 2014.

    Google Scholar 

  7. Cunningham FG, Leveno KJ, Bloom SL, Spong CY, Dashe JS, Hoffman BL, Casey BM, Sheffield JS. Fetal disorders. In: Williams obstetrics. 24th ed. New York: McGraw Hill Education; 2014. p. 306–20.

    Google Scholar 

  8. Johnson PR, Tait RC, Austin EB, Shwe KH, Lee D. Flow cytometry in diagnosis and management of large fetomaternal haemorrhage. J Clin Pathol. 1995;48:1005–8.

    Article  CAS  Google Scholar 

  9. Mollinson PL, Engelfreit CP, Contreras M. Development of immune anti-D Blood transfusion in clinical medicine. 10th ed. Oxford: Blackwell; 1997. p. 82.

    Google Scholar 

  10. Nicolaides KH, Rodeck CH. Maternal serum anti-D antibody concentration and assessment of rhesus isoimmunisation. Br Med J. 1992;304:1155–6.

    Article  CAS  Google Scholar 

  11. Fung Kee Fung K, Eason E, Crane J, et al. Prevention of Rh alloimmunization. J Obstet Gynaecol Can. 2003;25(9):765–73.

    Article  Google Scholar 

  12. Boggs TR Jr. Survival rates in Rh sensitizations: 140 interrupted versus 141 uninterrupted pregnancies. Pediatrics. 1964;33:758–62.

    PubMed  Google Scholar 

  13. Garabedian C, Rakza T, Drumez E, et al. Benefits of delayed cord clamping in red blood cell alloimmunization. Pediatrics. 2016;137(3):e20153236.

    Article  Google Scholar 

  14. British Committee for Standards in Haematology (BCSH), White J, Qureshi H, Massey E, Needs M, Byrne G, Daniels G, Allard S. Guideline for blood grouping and red cell antibody testing in pregnancy. Transfus Med. 2016;26(4):246–63. https://doi.org/10.1111/tme.12299.

    Article  Google Scholar 

  15. Hartwell E. Use of Rh immune globulin. ASCP Practice Parameter. Am J Clin Pathol. 1998;110:281–302.

    Article  CAS  Google Scholar 

  16. Qureshi H, Massey E, Kirwan D, Davies T, Robson S, White J, Jones J, Allard S, British Committee for Standards in Haematology (BCSH). Guideline for the use of anti-D immunoglobulin for the prevention of haemolytic disease of the fetus and newborn. Transfus Med. 2014;24(1):8–20.

    Article  CAS  Google Scholar 

  17. Kumar S, Regan F. Management of pregnancies with RhD alloimmunisation. BMJ. 2005;330(7502):1255–8.

    Article  Google Scholar 

  18. Moise KJ, Whitecar PW. Antenatal therapy for haemolytic disease of the fetus and newborn. In: Hadley A, Soothill P, editors. Alloimmune disorders in pregnancy. Anaemia, thrombocytopenia and neutropenia in the fetus and newborn. Cambridge, UK: Cambridge University Press; 2002. p. 141–63.

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2020 Springer Nature Singapore Pte Ltd.

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Aggarwal, R., Suneja, A. (2020). Rhesus-Negative Mother. In: Sharma, A. (eds) Labour Room Emergencies. Springer, Singapore. https://doi.org/10.1007/978-981-10-4953-8_17

Download citation

  • DOI: https://doi.org/10.1007/978-981-10-4953-8_17

  • Published:

  • Publisher Name: Springer, Singapore

  • Print ISBN: 978-981-10-4952-1

  • Online ISBN: 978-981-10-4953-8

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics